Standout Papers

Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or Er... 2001 2026 2009 2017 779
  1. Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial (2001)
    Matthew J. Ellis, Andrew Coop et al. Journal of Clinical Oncology

Immediate Impact

9 by Nobel laureates 27 from Science/Nature 131 standout
Sub-graph 1 of 20

Citing Papers

Computational approaches streamlining drug discovery
2023 StandoutNature
Structural snapshots of TRPV1 reveal mechanism of polymodal functionality
2021 StandoutNobel
2 intermediate papers

Works of Andrew Coop being referenced

Recent Advances in Ligand-Based Drug Design: Relevance and Utility of the Conformationally Sampled Pharmacophore Approach
2010
Identification of a New Class of Molecules, the Arachidonyl Amino Acids, and Characterization of One Member That Inhibits Pain
2001

Author Peers

Author Last Decade Papers Cites
Andrew Coop 1440 1873 493 1085 149 4.5k
Pui‐Kai Li 319 2953 771 1637 134 5.5k
Hildegard M. Schuller 762 2512 301 968 130 4.6k
Sarah J. Roberts‐Thomson 739 3395 130 606 106 5.6k
Serrine S. Lau 478 1686 278 397 124 3.6k
Gregory R. Monteith 958 3966 138 629 143 6.5k
Kevin R. Kozak 408 923 451 777 87 4.4k
Theodore M. Kamenecka 882 3975 996 684 147 8.1k
J. Scott Daniels 1509 2653 734 298 161 4.6k
Armando A. Genazzani 1618 3926 2362 1268 247 10.3k
Mats Carlquist 3358 4273 411 907 75 8.3k

All Works

Loading papers...

Rankless by CCL
2026